Berberine as a promising safe anti-cancer agent - is there a role for mitochondria?

Metabolic regulation is largely dependent on mitochondria, which play an important role in energy homeostasis. Imbalance between energy intake and expenditure leads to mitochondrial dysfunction, characterized by a reduced ratio of energy production (ATP production) to respiration. Due to the role of mitochondrial factors/events in several apoptotic pathways, the possibility of targeting that organelle in the tumor cell, leading to its elimination is very attractive, although the safety issue is problematic. Berberine, a benzyl-tetra isoquinoline alkaloid extracted from plants of the Berberidaceae family, has been extensively used for many centuries, especially in the traditional Chinese and Native American medicine. Several evidences suggest that berberine possesses several therapeutic uses, including anti-tumoral activity. The present review supplies evidence that berberine is a safe anti-cancer agent, exerting several effects on mitochondria, including inhibition of mitochondrial Complex I and interaction with the adenine nucleotide translocator which can explain several of the described effects on tumor cells.

[1]  S. Tsao,et al.  Berberine induces autophagic cell death and mitochondrial apoptosis in liver cancer cells: The cellular mechanism , 2010, Journal of cellular biochemistry.

[2]  Jinhe Kim,et al.  Berberine induces apoptosis in breast cancer cells (MCF-7) through mitochondrial-dependent pathway. , 2010, European journal of pharmacology.

[3]  M. Kheir,et al.  Acute toxicity of berberine and its correlation with the blood concentration in mice. , 2010, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[4]  Lisa M. Miller,et al.  Berberine and plant stanols synergistically inhibit cholesterol absorption in hamsters. , 2010, Atherosclerosis.

[5]  A. Dhir,et al.  Berberine: a plant alkaloid with therapeutic potential for central nervous system disorders , 2010, Phytotherapy research : PTR.

[6]  J. Hoheisel,et al.  Traditional Chinese medicines (TCMs) for molecular targeted therapies of tumours. , 2010, Current drug discovery technologies.

[7]  Sten Orrenius,et al.  The Warburg effect and mitochondrial stability in cancer cells. , 2010, Molecular aspects of medicine.

[8]  G. Scambia,et al.  Antiproliferative and antiangiogenic effects of the benzophenanthridine alkaloid sanguinarine in melanoma. , 2009, Biochemical pharmacology.

[9]  Yung-Hyun Choi,et al.  Sanguinarine sensitizes human gastric adenocarcinoma AGS cells to TRAIL-mediated apoptosis via down-regulation of AKT and activation of caspase-3. , 2009, Anticancer research.

[10]  Y. Tong,et al.  Berberine inhibits Rho GTPases and cell migration at low doses but induces G2 arrest and apoptosis at high doses in human cancer cells. , 2009, International journal of molecular medicine.

[11]  B Xie,et al.  Synergistic therapeutic actions of herbal ingredients and their mechanisms from molecular interaction and network perspectives. , 2009, Drug discovery today.

[12]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[13]  Chun Guo,et al.  Berberine induces p53-dependent cell cycle arrest and apoptosis of human osteosarcoma cells by inflicting DNA damage. , 2009, Mutation research.

[14]  P. Clarke,et al.  Cell-cycle control in the face of damage--a matter of life or death. , 2009, Trends in cell biology.

[15]  K. Jung,et al.  Sanguinarine induces apoptosis in A549 human lung cancer cells primarily via cellular glutathione depletion. , 2009, Toxicology in vitro : an international journal published in association with BIBRA.

[16]  B. Zhivotovsky,et al.  Mitochondria as targets for chemotherapy , 2009, Apoptosis.

[17]  S. Katiyar,et al.  p53 cooperates berberine‐induced growth inhibition and apoptosis of non‐small cell human lung cancer cells in vitro and tumor xenograft growth in vivo , 2009, Molecular carcinogenesis.

[18]  P. Oliveira,et al.  Sanguinarine cytotoxicity on mouse melanoma K1735-M2 cells--nuclear vs. mitochondrial effects. , 2008, Biochemical pharmacology.

[19]  Wei-Jia Kong,et al.  Reduction of blood lipid by berberine in hyperlipidemic patients with chronic hepatitis or liver cirrhosis. , 2008, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[20]  P. Oliveira,et al.  Mechanisms of berberine (natural yellow 18)-induced mitochondrial dysfunction: interaction with the adenine nucleotide translocator. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[21]  J. Mackey,et al.  Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer , 2008, British Journal of Cancer.

[22]  V. Shoshan-Barmatz,et al.  Methyl jasmonate binds to and detaches mitochondria-bound hexokinase , 2008, Oncogene.

[23]  H. Hosseinzadeh,et al.  Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine , 2008, Phytotherapy research : PTR.

[24]  Wei-Jia Kong,et al.  Combination of simvastatin with berberine improves the lipid-lowering efficacy. , 2008, Metabolism: clinical and experimental.

[25]  Yung-Hyun Choi,et al.  Sanguinarine, a Benzophenanthridine Alkaloid, Induces Apoptosis in MDA-MB-231 Human Breast Carcinoma Cells through a Reactive Oxygen Species-Mediated Mitochondrial Pathway , 2008, Chemotherapy.

[26]  G. Ning,et al.  Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. , 2008, The Journal of clinical endocrinology and metabolism.

[27]  B. Aggarwal,et al.  Berberine modifies cysteine 179 of IkappaBalpha kinase, suppresses nuclear factor-kappaB-regulated antiapoptotic gene products, and potentiates apoptosis. , 2008, Cancer research.

[28]  Y. Yoo,et al.  Sanguinarine-Induced Apoptosis in Human Leukemia U937 Cells via Bcl-2 Downregulation and Caspase-3 Activation , 2008, Chemotherapy.

[29]  Jianping Ye,et al.  Efficacy of berberine in patients with type 2 diabetes mellitus. , 2008, Metabolism: clinical and experimental.

[30]  P. Oliveira,et al.  Different concentrations of berberine result in distinct cellular localization patterns and cell cycle effects in a melanoma cell line , 2008, Cancer Chemotherapy and Pharmacology.

[31]  R. Park,et al.  Berberine induces G1 arrest and apoptosis in human glioblastoma T98G cells through mitochondrial/caspases pathway. , 2008, Biological & pharmaceutical bulletin.

[32]  R. Stoika,et al.  A decisive role of mitochondria in defining rate and intensity of apoptosis induction by different alkaloids. , 2008, Toxicology letters.

[33]  M. Butterworth,et al.  A novel paradigm for rapid ABT-737-induced apoptosis involving outer mitochondrial membrane rupture in primary leukemia and lymphoma cells , 2008, Cell Death and Differentiation.

[34]  Seung Joon Baek,et al.  Berberine, a natural isoquinoline alkaloid, induces NAG-1 and ATF3 expression in human colorectal cancer cells. , 2007, Cancer letters.

[35]  P. Oliveira,et al.  Mitochondrially Targeted Effects of Berberine [Natural Yellow 18, 5,6-dihydro-9,10-dimethoxybenzo(g)-1,3-benzodioxolo(5,6-a) quinolizinium] on K1735-M2 Mouse Melanoma Cells: Comparison with Direct Effects on Isolated Mitochondrial Fractions , 2007, Journal of Pharmacology and Experimental Therapeutics.

[36]  Hui-Ju Lin,et al.  GADD153 mediates berberine-induced apoptosis in human cervical cancer Ca ski cells. , 2007, Anticancer research.

[37]  Shun-Fa Yang,et al.  Berberine induces apoptosis in SW620 human colonic carcinoma cells through generation of reactive oxygen species and activation of JNK/p38 MAPK and FasL , 2007, Archives of Toxicology.

[38]  M. López-Lázaro Digitoxin as an anticancer agent with selectivity for cancer cells: possible mechanisms involved , 2007, Expert opinion on therapeutic targets.

[39]  Peng Huang,et al.  The Warburg effect and its cancer therapeutic implications , 2007, Journal of bioenergetics and biomembranes.

[40]  L. Platanias,et al.  Sanguinarine-dependent induction of apoptosis in primary effusion lymphoma cells. , 2007, Cancer research.

[41]  Xiu-fang Wang,et al.  Mitocans as anti-cancer agents targeting mitochondria: lessons from studies with vitamin E analogues, inhibitors of complex II , 2007, Journal of bioenergetics and biomembranes.

[42]  L. Cipak,et al.  Berberine induces apoptosis through a mitochondrial/caspase pathway in human promonocytic U937 cells. , 2007, Toxicology in vitro : an international journal published in association with BIBRA.

[43]  W. Sadee,et al.  Glucose uptake inhibitor sensitizes cancer cells to daunorubicin and overcomes drug resistance in hypoxia , 2007, Cancer Chemotherapy and Pharmacology.

[44]  H. Nakamura,et al.  Tumor-targeted induction of oxystress for cancer therapy , 2007, Journal of drug targeting.

[45]  Peng Huang,et al.  Mitochondrial respiration defects in cancer cells cause activation of Akt survival pathway through a redox-mediated mechanism , 2006, The Journal of cell biology.

[46]  R. Youle,et al.  How do Bax and Bak lead to permeabilization of the outer mitochondrial membrane? , 2006, Current opinion in cell biology.

[47]  L. Yao,et al.  Resveratrol-induced cell inhibition of growth and apoptosis in MCF7 human breast cancer cells are associated with modulation of phosphorylated akt and caspase-9 , 2006, Applied biochemistry and biotechnology.

[48]  R. Dhir,et al.  Phenethyl isothiocyanate-induced apoptosis in PC-3 human prostate cancer cells is mediated by reactive oxygen species-dependent disruption of the mitochondrial membrane potential. , 2006, Carcinogenesis.

[49]  C. Scott,et al.  The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized. , 2006, Cancer cell.

[50]  H. Pehamberger,et al.  Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the Oblimersen Melanoma Study Group. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[51]  S. Katiyar,et al.  Berberine inhibits growth, induces G1 arrest and apoptosis in human epidermoid carcinoma A431 cells by regulating Cdki-Cdk-cyclin cascade, disruption of mitochondrial membrane potential and cleavage of caspase 3 and PARP. , 2006, Carcinogenesis.

[52]  D. Albert,et al.  Mitochondria as the primary target of resveratrol-induced apoptosis in human retinoblastoma cells. , 2006, Investigative ophthalmology & visual science.

[53]  Jinsong Liu,et al.  Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate. , 2006, Cancer cell.

[54]  S. Zunino,et al.  Resveratrol-induced apoptosis is enhanced in acute lymphoblastic leukemia cells by modulation of the mitochondrial permeability transition pore. , 2006, Cancer letters.

[55]  N. Hay,et al.  Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt , 2006, Oncogene.

[56]  G. Kroemer,et al.  Mitochondria in cancer , 2006, Oncogene.

[57]  D. James,et al.  Berberine, a Natural Plant Product, Activates AMP-Activated Protein Kinase With Beneficial Metabolic Effects in Diabetic and Insulin-Resistant States , 2006, Diabetes.

[58]  Yan Zhao,et al.  Vitamin E analogues as anticancer agents: Lessons from studies with α‐tocopheryl succinate , 2006 .

[59]  Y. Hsieh,et al.  Inhibitory effect of berberine on the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2. , 2006, Toxicology and applied pharmacology.

[60]  P. Leder,et al.  Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. , 2006, Cancer cell.

[61]  V. Shoshan-Barmatz,et al.  The voltage-dependent anion channel (VDAC): function in intracellular signalling, cell life and cell death. , 2006, Current pharmaceutical design.

[62]  P. Oliveira,et al.  Depletion of adenine nucleotide translocator protein in heart mitochondria from doxorubicin-treated rats--relevance for mitochondrial dysfunction. , 2006, Toxicology.

[63]  C. Ting,et al.  Berberine suppresses MEK/ERK-dependent Egr-1 signaling pathway and inhibits vascular smooth muscle cell regrowth after in vitro mechanical injury. , 2006, Biochemical pharmacology.

[64]  S. Katiyar,et al.  Berberine, a natural product, induces G1-phase cell cycle arrest and caspase-3-dependent apoptosis in human prostate carcinoma cells , 2006, Molecular Cancer Therapeutics.

[65]  S. Letašiová,et al.  Effect of berberine on proliferation, biosynthesis of macromolecules, cell cycle and induction of intercalation with DNA, dsDNA damage and apoptosis in Ehrlich ascites carcinoma cells , 2006, The Journal of pharmacy and pharmacology.

[66]  J. Y. Liu,et al.  Berberine induces apoptosis through a mitochondria/caspases pathway in human hepatoma cells , 2006, Archives of Toxicology.

[67]  T. Schulz,et al.  Induction of Oxidative Metabolism by Mitochondrial Frataxin Inhibits Cancer Growth , 2006, Journal of Biological Chemistry.

[68]  Jai-Sing Yang,et al.  Berberine induces cell cycle arrest and apoptosis in human gastric carcinoma SNU-5 cell line. , 2006, World journal of gastroenterology.

[69]  Y. Jang,et al.  Berberine inhibits the production of lysophosphatidylcholine-induced reactive oxygen species and the ERK1/2 pathway in vascular smooth muscle cells. , 2005, Molecules and cells.

[70]  M. Gleave,et al.  A novel antisense oligonucleotide inhibiting several antiapoptotic Bcl-2 family members induces apoptosis and enhances chemosensitivity in androgen-independent human prostate cancer PC3 cells , 2005, Molecular Cancer Therapeutics.

[71]  J. Gledhill,et al.  Inhibition sites in F1-ATPase from bovine heart mitochondria. , 2005, The Biochemical journal.

[72]  A. Gosslau,et al.  A methoxy derivative of resveratrol analogue selectively induced activation of the mitochondrial apoptotic pathway in transformed fibroblasts , 2005, British Journal of Cancer.

[73]  Peng Huang,et al.  Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia. , 2005, Cancer research.

[74]  D. Hockenbery,et al.  Promises and challenges of targeting Bcl-2 anti-apoptotic proteins for cancer therapy. , 2004, Biochimica et biophysica acta.

[75]  Satoru Inaba,et al.  Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins , 2004, Nature Medicine.

[76]  Hans-Dieter Höltje,et al.  Human topoisomerase I poisoning: docking protoberberines into a structure-based binding site model , 2004, J. Comput. Aided Mol. Des..

[77]  J. Modica-Napolitano,et al.  Mitochondrial dysfunction in cancer. , 2004, Mitochondrion.

[78]  V. Kettmann,et al.  In vitro cytotoxicity of berberine against HeLa and L1210 cancer cell lines. , 2004, Die Pharmazie.

[79]  Peng Huang,et al.  ROS stress in cancer cells and therapeutic implications. , 2004, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[80]  Herbert Schneckenburger,et al.  Fluorescence lifetime imaging (FLIM) of rhodamine 123 in living cells , 2004, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[81]  J. Arrabaça,et al.  Inhibition of mouse liver respiration by Chelidonium majus isoquinoline alkaloids. , 2003, Toxicology letters.

[82]  L. Cipak,et al.  Effect of berberine on proliferation, cell cycle and apoptosis in HeLa and L1210 cells , 2003, The Journal of pharmacy and pharmacology.

[83]  B. G. Sanders,et al.  RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells involves Bax translocation to mitochondria. , 2003, Cancer research.

[84]  J. Folkman,et al.  A peptide trivalent arsenical inhibits tumor angiogenesis by perturbing mitochondrial function in angiogenic endothelial cells. , 2003, Cancer cell.

[85]  A. Halestrap,et al.  Role of critical thiol groups on the matrix surface of the adenine nucleotide translocase in the mechanism of the mitochondrial permeability transition pore. , 2002, The Biochemical journal.

[86]  J. P. Fawcett,et al.  The involvement of P-glycoprotein in berberine absorption. , 2002, Pharmacology & toxicology.

[87]  Luca Scorrano,et al.  A novel mitochondriotoxic small molecule that selectively inhibits tumor cell growth. , 2002, Cancer cell.

[88]  V. Gogvadze,et al.  Fas‐triggered phosphatidylserine exposure is modulated by intracellular ATP , 2002, FEBS letters.

[89]  J. Hoek,et al.  Mitochondrial Binding of Hexokinase II Inhibits Bax-induced Cytochrome c Release and Apoptosis* , 2002, The Journal of Biological Chemistry.

[90]  M. Madesh,et al.  VDAC-dependent permeabilization of the outer mitochondrial membrane by superoxide induces rapid and massive cytochrome c release , 2001, The Journal of cell biology.

[91]  J. Modica-Napolitano,et al.  Delocalized lipophilic cations selectively target the mitochondria of carcinoma cells. , 2001, Advanced drug delivery reviews.

[92]  A. Terpstra Differences between humans and mice in efficacy of the body fat lowering effect of conjugated linoleic acid: role of metabolic rate. , 2001, The Journal of nutrition.

[93]  R. Greil,et al.  Resveratrol, a tumor‐suppressive compound from grapes, induces apoptosis via a novel mitochondrial pathway controlled by Bcl‐2 , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[94]  D. Voehringer,et al.  Understanding and exploiting the mechanistic basis for selectivity of polyketide inhibitors of F(0)F(1)-ATPase. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[95]  X. Yao,et al.  Vasorelaxant and antiproliferative effects of berberine. , 2000, European journal of pharmacology.

[96]  G. Kroemer,et al.  Oxidation of a critical thiol residue of the adenine nucleotide translocator enforces Bcl-2-independent permeability transition pore opening and apoptosis , 2000, Oncogene.

[97]  R. Laucirica,et al.  Loss of anti-mitotic effects of Bcl-2 with retention of anti-apoptotic activity during tumor progression in a mouse model , 1999, Oncogene.

[98]  H. Wu,et al.  Berberine‐induced apoptosis of human leukemia HL‐60 cells is associated with down‐regulation of nucleophosmin/B23 and telomerase activity , 1999, International journal of cancer.

[99]  D. V. Von Hoff,et al.  Activity of MKT 077, a rhodacyanine dye, against human tumor colony-forming units. , 1999, Anti-cancer drugs.

[100]  T. Maeda,et al.  K‐252a‐induced polyploidization and differentiation of a human megakaryocytic cell line, Meg‐J: transient elevation and subsequent suppression of cyclin B1 and cdc2 expression in the process of polyploidization , 1998, British journal of haematology.

[101]  A. Strasser,et al.  The cell death inhibitor Bcl‐2 and its homologues influence control of cell cycle entry. , 1996, The EMBO journal.

[102]  Shishido,et al.  MKT-077, a novel rhodacyanine dye in clinical trials, exhibits anticarcinoma activity in preclinical studies based on selective mitochondrial accumulation. , 1996, Cancer research.

[103]  J. Modica-Napolitano,et al.  Selective damage to carcinoma mitochondria by the rhodacyanine MKT-077. , 1996, Cancer research.

[104]  Ni Yx Therapeutic effect of berberine on 60 patients with type II diabetes mellitus and experimental research , 1988 .

[105]  R. Salem,et al.  Dequalinium, a topical antimicrobial agent, displays anticarcinoma activity based on selective mitochondrial accumulation. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[106]  T. Lampidis,et al.  Anticarcinoma activity in vivo of rhodamine 123, a mitochondrial-specific dye. , 1983, Science.

[107]  V. Mikes,et al.  Berberine derivatives as cationic fluorescent probes for the investigation of the energized state of mitochondria. , 1983, Biochimica et biophysica acta.

[108]  I. Summerhayes,et al.  Selective toxicity of rhodamine 123 in carcinoma cells in vitro. , 1983, Cancer research.

[109]  I. Summerhayes,et al.  Rhodamine-123 selectively reduces clonal growth of carcinoma cells in vitro. , 1982, Science.

[110]  I. Summerhayes,et al.  Unusual retention of rhodamine 123 by mitochondria in muscle and carcinoma cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[111]  A. Zelenin,et al.  [Fluorescence microscopy demonstration of mitochondria in tissue culture cells using berberine]. , 1977, Tsitologiia.

[112]  T. Subbaiah,et al.  Berberine sulfate: antimicrobial activity, bioassay, and mode of action. , 1969, Canadian journal of microbiology.

[113]  O. Warburg [Origin of cancer cells]. , 1956, Oncologia.

[114]  Jianping Ye,et al.  Berberine improves glucose metabolism through induction of glycolysis. , 2008, American journal of physiology. Endocrinology and metabolism.

[115]  Jing-Gung Chung,et al.  Apoptosis of human leukemia HL-60 cells and murine leukemia WEHI-3 cells induced by berberine through the activation of caspase-3. , 2006, Anticancer research.

[116]  B. Baysal Role of mitochondrial mutations in cancer , 2006, Endocrine pathology.

[117]  C. Chi,et al.  Modulation of apoptosis by berberine through inhibition of cyclooxygenase-2 and Mcl-1 expression in oral cancer cells. , 2005, In vivo.

[118]  M. D. Faddeeva,et al.  [Inhibition of liver mitochondrial monoamine oxidase activity by alkaloids isolated from Chelidonium and Macleaya and by their derivative drugs]. , 2003, Tsitologiia.

[119]  Da-yuan Zhu,et al.  Identification of three sulfate-conjugated metabolites of berberine chloride in healthy volunteers' urine after oral administration. , 2002, Acta pharmacologica Sinica.

[120]  S. Korsmeyer,et al.  Bax accelerates tumorigenesis in p53-deficient mice. , 2001, Cancer research.

[121]  H. Kerl,et al.  Effect of dequalinium on K1735-M2 melanoma cell growth, directional migration and invasion in vitro. , 1992, European journal of cancer.